Glaxo projects sales boost from shingles vaccine

//Glaxo projects sales boost from shingles vaccine

Glaxo projects sales boost from shingles vaccine

GlaxoSmithKline (GSK) forecast that 2019 sales of its shingles vaccine would be more than £1bn (€1.1bn) but the drugmaker’s shares slipped on concerns about its pharmaceutical business and free cash flow.

Article by [author-name] (c) Business: BreakingNews.ie - Read full story here.

By | 2019-05-02T07:30:00+00:00 May 2nd, 2019|Business|Comments Off on Glaxo projects sales boost from shingles vaccine